Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00716742 · ClinicalTrials.gov registry record
Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 1,099
- Enrollment target
NCT00716742: Completed study, sponsored by Allergan.
NCT00716742 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 1,099 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00716742 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 1,099 participants
- Enrollment target
Study Summary
To investigate the effectiveness of the newer IOP-lowering therapies, as prescribed in normal clinical practice, in larger patient numbers. Patients will be assessed at baseline, at each follow-up visit (follow-up visits are variable as per physician discretion) and at final follow-up visit.
Primary Outcome
Change from baseline in bilateral (both eyes) IOP at the 1 year follow-up visit. IOP is a measure of the fluid pressure inside the eye. The bilateral IOP was calculated as an average between both eye's IOP. A negative number change from baseline indicates reduction in IOP (improvement).
Interventions
- DRUG bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,099 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-09 |
What the finished NCT00716742 record still lists
NCT00716742 is an observational study that tracks outcomes without assigning an intervention. Its 1,099 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004% is the first listed.
NCT00716742 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00716742 about?
NCT00716742 is a clinical study titled "Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)". To investigate the effectiveness of the newer IOP-lowering therapies, as prescribed in normal clinical practice, in larger patient numbers. Patients will be assessed at baseline, at each follow-up visit (follow-up visits are variable as per physician discretion) and at final follow-up visit.
What is the current status of trial NCT00716742?
This trial is currently completed. The enrollment target is 1,099 participants. The study started on 2004-09. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00716742?
The interventions under investigation include: bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004% (DRUG).
Who is sponsoring clinical trial NCT00716742?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia